美股市场个股详情

AMRN 阿玛琳

添加自选

0.839
-0.082-8.86%

收盘价 05/01 16:00 (美东)

0.850
+0.011+1.26%

盘后 19:26 (美东)

3.45亿总市值-6456市盈率TTM

阿玛琳股票讨论区

登录发表评论

Trytosaveabit

04/08 16:49

$阿玛琳(AMRN.US)$ Reported Saturday, New REDUCE-IT Analyses By Amarin Show That VASCEPA/VAZKEPA Benefits High-Risk Cardiovascular Disease Patient Subgroups

Trytosaveabit

04/08 01:02

Keep your eyes on!

$阿玛琳(AMRN.US)$ Just thinking outloud

Trytosaveabit

04/03 20:11

Update

$阿玛琳(AMRN.US)$ Amarin Received Decision To Grant From European Patent Office For New Patent Covering VAZKEPA That Will Extend VAZKEPA Exclusivity Eight Additional Years Into 2039

Trytosaveabit

02/29 20:26

Update! Nice!

$阿玛琳(AMRN.US)$ Amarin Says Initiated Shareholder Approval Process To Execute Share Repurchase Program Of Up To $50M By End Of Q2 2024

Trytosaveabit

01/25 06:36

Insider buy

$阿玛琳(AMRN.US)$ Officer Holt Patrick purchased 14,426 shares of Common Stocks on Jan 22, 2024 at an average price of $1.09 for a total value of $15,724.34.

SpyderCall

01/10 23:06

News

$阿玛琳(AMRN.US)$ Amarin Plans To Initiate Share Repurchase Program of Up to $50M
Moomoo 24/7· 1 min ago

GemHunter

2023/11/02 22:20

Amarin's low P/S ratio is due to declining revenue and expectations of below-average growth. Lack of investor confidence in future revenue growth may further affect its share price if no improvements are made.